Nirav R. Shah, MD, MPH, is the Senior Vice President and Chief Operating Officer of Clinical Operations for Kaiser Permanente’s Southern California region, a $24B health system with 14 hospitals, 168 medical offices and over 4 million members. He oversees health plan and hospital quality, service, accreditation, regulatory compliance, and licensure, as well as nursing, the continuum of care, and the effective use of technology, data, and analytics to produce better patient health outcomes. He also serves as a key liaison with the Southern California Permanente Medical Group for medical education, graduate medical education, and research as well as the planned new Kaiser Permanente Medical School.
Dr. Shah is board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He has been an RWJ Clinical Scholar at UCLA, attending physician at Bellevue Hospital in Manhattan, associate investigator at Geisinger Health in central Pennsylvania, and on the faculty of NYU Medical Center in the section of value and comparative effectiveness. Most recently, he served as commissioner of the New York State Department of Health.
Dr. Shah is an elected member of the Institute of Medicine of the National Academy of Sciences. He has served as a director for dozens of public and private institutions, as the chairman of National Institutes of Health (NIH) grant review panels, on the editorial boards of medical journals, received numerous NIH grants, and published over 100 peer-reviewed articles. He is a nationally recognized thought leader in patient safety and quality, health information technology, population health, and the strategies required to transition to lower-cost, patient-centered health care.
Creating an environment that engenders trust is critical, but is it measurable?
In health care, we deliver very little quality when defined by a metric that matters most to patients.
Blog Post by Nirav R. Shah, Anna C. Davis, Michael K. Gould & Michael H. Kanter
How Kaiser Permanente segments the top 1% of patients to gauge the intensity of care needed by nine risk-stratified subgroups.